Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-13 · accession 0002048466-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-14 | 2026-01-13 | BBNX | Lezack Adam | Dir | A - Grant | $0.00 | +3,997 | 12.4K | +47% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-13 | A | A | 3,997 | $0.00 | 12,432 | D | — | — | (F1) Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. |